David Stoots
Surgical · Birmingham, ALNPI 1326664095
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,628 of the $2,592 with a category attached, or 62.8%. 9 manufacturers reported payments, led by Zimmer Biomet at 49.9% of the total. 2025 is the largest year on record at $1,164, 4.2 times the $274 reported in 2021.
Across 30 payments — averaging $86.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$1K
- Pacira Pharmaceuticals Incorporated$991
- Medical Device Business Services, Inc.$95
- Johnson & Johnson$85
- Pacira Therapeutics, Inc.$38
- Smith+Nephew$30
- plus $58 from 3 others
What the payments were for
- Travel & lodging$1,62863%
- Food & beverage$96437%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 10 | $1,295 |
| Pacira Pharmaceuticals Incorporated | 7 | $991 |
| Medical Device Business Services, Inc. | 1 | $95 |
| Johnson & Johnson(2 entities) | 6 | $85 |
| Pacira Therapeutics, Inc. | 2 | $38 |
| Smith+Nephew | 1 | $30 |
| Bioventus LLC | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,592 in reported general payments places this provider in the 80th percentile of 162 surgical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 45 | $404 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $396 |
| Ondansetron Hcl | 39 | $309 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $263 |
| Naproxen | 40 | $180 |
| Methocarbamol | 33 | $163 |
| Oxycodone Hcl | 17 | $127 |
| Cefdinir | 31 | $91 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $90 |
| Meloxicam | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other surgical in Birmingham
- Heather ForsonBirmingham$8K
- Suzanne Powe VickersBirmingham$8K
- Samuel MurphreeBirmingham$6K
- Kelsey KoesterBirmingham$4K
- Timothy TreloarBirmingham$4K
- Ronald PhilleyBirmingham$3K
- Allison SeamonBirmingham$3K
- Priya PatelBirmingham$3K
- Jody St ClairBirmingham$3K
- Amy SchalkBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.